ARCHIVES

Phase III Trial Shows Benefit For Old Drugs, Old Device, For Ovarian Cancer, But Will Practice Change?

This article is from The Cancer Letter archive.

Vol. 32 No. 02 | January 20, 2006

Download PDF Visit The Full Archive

Related Articles

The Cancer Letter Takes Summer Publication Break.

August 2, 2002

Court Forces CPSC To Reopen Carcinogen Policy

January 19, 1979

In Brief: Wittes to Join Bristol-Myers As VP; Friedman Named Acting CTEP Director; Carl Pinsky Leaves

September 23, 1988

Mack, to Retire, Calls Budget Proposal an “Act of Retreat”

March 19, 1999

Flexibility OK In Paying Grants If Justified, Upton Affirms

September 1, 1978

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

April 26, 2002